| Combination therapy: opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines F Greco, MJ Vicent Advanced drug delivery reviews 61 (13), 1203-1213, 2009 | 747 | 2009 |
| Polymer conjugates: nanosized medicines for treating cancer MJ Vicent, R Duncan Trends in biotechnology 24 (1), 39-47, 2006 | 607 | 2006 |
| Polymer therapeutics-prospects for 21st century: the end of the beginning R Duncan, MJ Vicent Advanced drug delivery reviews 65 (1), 60-70, 2013 | 498 | 2013 |
| Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics M Barz, R Luxenhofer, R Zentel, MJ Vicent Polymer Chemistry 2 (9), 1900-1918, 2011 | 459 | 2011 |
| Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities R Duncan, MJ Vicent Advanced drug delivery reviews 62 (2), 272-282, 2010 | 290 | 2010 |
| Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer R Duncan, MJ Vicent, F Greco, RI Nicholson Endocrine-related cancer 12 (Supplement_1), S189-S199, 2005 | 286 | 2005 |
| Polymer therapeutics designed for a combination therapy of hormone‐dependent cancer MJ Vicent, F Greco, RI Nicholson, A Paul, PC Griffiths, R Duncan Angewandte Chemie 117 (26), 4129-4134, 2005 | 263 | 2005 |
| Polymer therapeutics: clinical applications and challenges for development MJ Vicent, H Ringsdorf, R Duncan Advanced drug delivery reviews 13 (61), 1117-1120, 2009 | 240 | 2009 |
| Current hurdles to the translation of nanomedicines from bench to the clinic S Đorđević, MM Gonzalez, I Conejos-Sánchez, B Carreira, S Pozzi, ... Drug delivery and translational research, 1-26, 2022 | 221 | 2022 |
| Polymer–drug conjugates as nano-sized medicines F Canal, J Sanchis, MJ Vicent Current opinion in biotechnology 22 (6), 894-900, 2011 | 194 | 2011 |
| Polymer-drug conjugates: current status and future trends F Greco, MJ Vicent Front Biosci 13 (13), 2744-2756, 2008 | 150 | 2008 |
| Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy I Casanova-Salas, J Rubio-Briones, A Calatrava, C Mancarella, E Masiá, ... The Journal of urology 192 (1), 252-259, 2014 | 145 | 2014 |
| Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel A Eldar-Boock, K Miller, J Sanchis, R Lupu, MJ Vicent, R Satchi-Fainaro Biomaterials 32 (15), 3862-3874, 2011 | 143 | 2011 |
| A controlled and versatile NCA polymerization method for the synthesis of polypeptides I Conejos-Sánchez, A Duro-Castano, A Birke, M Barz, MJ Vicent Polymer Chemistry 4 (11), 3182-3186, 2013 | 138 | 2013 |
| Peptide-based polymer therapeutics A Duro-Castano, I Conejos-Sánchez, MJ Vicent Polymers 6 (2), 515-551, 2014 | 128 | 2014 |
| How important is the inert matrix of supported enantiomeric catalysts? Reversal of topicity with two polystyrene backbones B Altava, MI Burguete, JM Fraile, JI García, SV Luis, JA Mayoral, ... Angewandte Chemie 112 (8), 1563-1566, 2000 | 122 | 2000 |
| The past, present, and future of breast cancer models for nanomedicine development P Boix-Montesinos, PM Soriano-Teruel, A Arminan, M Orzaez, MJ Vicent Advanced drug delivery reviews 173, 306-330, 2021 | 115 | 2021 |
| Polymer–drug conjugates for novel molecular targets J Sanchis, F Canal, R Lucas, MJ Vicent Nanomedicine 5 (6), 915-935, 2010 | 112 | 2010 |
| Smart branched polymer drug conjugates as nano-sized drug delivery systems A Duro-Castano, J Movellan, MJ Vicent Biomaterials science 3 (10), 1321-1334, 2015 | 111 | 2015 |
| Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer–Dox–AGM in breast cancer cells F Greco, MJ Vicent, S Gee, AT Jones, J Gee, RI Nicholson, R Duncan Journal of Controlled Release 117 (1), 28-39, 2007 | 111 | 2007 |
Francesca GrecoUniversity of ReadingDirección de correo verificada de reading.ac.uk
